NeuroPace, Inc.

NPCE· NASDAQ· Health Care· Health Care Equipment & Services

$13.50+4.73%

2026-08-03

Financials

Valuation Metrics

NeuroPace, Inc.'s Market Cap is $460M. At end of 2025 it was $505M. Ranked #2844 of 3,111 in US market (top 91%), #1251 of 1,445 on NASDAQ (top 87%), #176 of 206 in Health Care Equipment & Services (top 85%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$460M	US#2,844/3,111 Sec#176/206
Revenue	$100M	US#2,786/3,111 Sec#190/206
Net Income	$-22M	US—/3,111 Sec—/206
Total Assets	$99M	US#3,048/3,111 Sec#204/206
Net Assets	$14M	US#2,993/3,111 Sec#204/206
Value
P/B	31.84x	US#2,890/3,111 Sec#195/206
P/S	4.62x	US#2,181/3,111 Sec#153/206
FCF Yield	-2.14%	US—/3,111 Sec—/206
Profitability
ROE	-149.20%	US#2,894/3,111 Sec#191/206
ROA	-21.81%	US#2,806/3,111 Sec#180/206
Op. Margin	-16.84%	US#2,688/3,111 Sec#168/206
Revenue Growth	-2.02%	US#2,390/3,111 Sec#173/206
Financial Health
Debt Ratio	584.23%	US#2,445/3,111 Sec#191/206
Total Debt	$70M	US#2,507/3,111 Sec#145/206
FCF	$-10M	US#2,334/3,111 Sec#157/206
Cash	$15M	US#2,918/3,111 Sec#198/206
Current Ratio	5.38x	US#438/3,111 Sec#36/206
Performance
1Y Return	50.17%	US#692/3,111 Sec#52/206
1M Return	-16.36%	US#2,797/3,111 Sec#187/206
From 52W High	-31.12%	US#2,279/3,111 Sec#154/206
1Y MDD	-54.50%	US#2,552/3,111 Sec#155/206
Trading
Volume	590,807 shares	US#2,319/3,111 Sec#166/206
Trading Value	$8M	US#2,680/3,111 Sec#170/206
Per Share
EPS	$-0.66	US—/3,111 Sec—/206
BPS	$0.58	US#2,680/3,111 Sec#190/206